cbdMD: Akretive acquires approximately 15.9% stake
Akretive Holdings’ shares represent approximately 15.9% of YCBD’s outstanding common stock, with a director nominee subject to committee consideration.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
cbdMD, Inc. (YCBD) reports that Akretive Holdings, LLC acquired 2,229,805 common shares on October 30, 2026, under an Asset Purchase Agreement dated September 1, 2026. The shares represented approximately 15.9% of cbdMD’s 14,048,386 outstanding common shares as of October 30, 2026. Patrick Ogle, managing member of Akretive LLC, has sole power to vote or direct the vote, and to dispose or direct the disposition, of the shares beneficially owned by Akretive Holdings. The agreement gives Akretive Holdings the right to nominate a director for the issuer’s Nominating and Corporate Governance Committee to consider. The reporting person also acquired a Senior Secured Promissory Note.
Key Figures
Key Terms
Asset Purchase Agreement financial
Senior Secured Promissory Note financial
beneficially owns regulatory
sole power to vote regulatory
right to nominate a director regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Did Akretive Holdings make other YCBD stock transactions during the prior 60 days?
AI-generated analysis. How Rhea-AI works. Not financial advice.